The prevalence of chronic heart failure and risks stratification of early post-hospital letality (review)
The analysis of the prevalence of chronic heart failure, the difficulties of diagnosis and dispensary observation of patients with chronic heart failure. Accurate prediction of the individual risk of mortality, especially in the early period after hospitalization, as well as stratification of the risks of developing lethal and non-lethal complications of chronic heart failure is a strategic task of modern medicine and can be achieved by using mathematical prediction models. Diagnosis of heart failure, especially at the onset of the disease, is very difficult, so in the early stages, patients seek medical help mainly because of low-specific symptoms, which in turn does not allow the doctor to timely carry out differential diagnosis of heart failure with other diseases. ECG is a widely available diagnostic method and is an important prognostic marker of post-hospital mortality in patients with heart failure. Low voltage ECG is a marker of the severity of chronic heart failure and is a risk factor for serious consequences for patients with systolic chronic heart failure within 1 year. It is necessary to take into account the variance of the QRS complex as an important diagnostic criterion.
Alyoshechkin P.A., Schukina E.V., Tsiba I.N., Shevchenko A.S., Vasilenko V.V., Shulik A.I. 2021. The prevalence of chronic heart failure and risks stratification of early post-hospital letality (review). Challenges in Modern Medicine. 44 (3): 305–318 (in Russian). DOI: 10.52575/2687-0940-2021-44-3-305-318
While nobody left any comments to this publication.
You can be first.
Alieva A.M. 2017. Natrijureticheskie peptidy: ispol'zovanie v sovremennoj kardiologii. Atmosfera. Novosti kardiologii [Natriuretic peptides: use in modern cardiology. Atmosphere. Cardiology news], 1: 26–31.
Balykova L.A., Leontyeva I.V., Urzyaeva N.N., Schekina N.V., Petrushkina Yu.A., Ivyanskaya N.V., Soloviev V.M. 2018. Miokardit s ishodom v dilatatsionnuyu kardiomiopatiyu, slozhnennuyu refrakternoy serdechnoy nedostatochnostyu i potrebovavshuyu transplantatsii serdtsa. Rossiyskiy vestnik perinatologii i pediatrii [Myocarditis with outcome in dilated cardiomyopathy complicated by refractory heart failure and requiring heart transplantation]. Rossijskij vestnik perinatologii i pediatrii, 63 (3): 105–111.
Barsukov A.V. Gulyaev N.I., Mitrofanova L.B., Shishkevich A.N., Sajfullin R.F., Yаkovlev V.V., Yakovlev V.A. 2018. K voprosu o regulyarnom primenenii levosimendana pri tyazheloy hronicheskoy serdechnoy nedostatochnosti nekoronarogennogo proishozhdeniya. Vestnik Natsionalnogo mediko-hirurgicheskogo Tsentra im. N.I. Pirogova [The regular application of levosimendan at the heavy chronic cardiac insufficiency of non-coronary origin]. Vestnik Nacional'nogo mediko-hirurgicheskogo Centra im. N.I. Pirogova, 13(4): 162–165.
Larina V.N., Chukaeva I.I. 2016. Diagnostika i lechenie hronicheskoj serdechnoj nedostatochnosti (po rekomendacij Evropejskogo obshhestva kardiologov po diagnostike i lecheniju ostroj i hronicheskoj serdechnoj nedostatochnosti 2016 g.) [Diagnostics and treatment of chronic heart failure (according to the recommendations of the European Society of Cardiology for the diagnosis and treatment of acute and chronic heart failure 2016). Medicine]. Lechebnoe delo, 3: 37–48.
Mareev V.Ju., Fomin I.V., Ageev F.T., Begrambekova Yu.L., Vasyuk Yu.A., Garganeeva A.A., Gendlin G.E., Glezer M.G., Gautier S.V., Dovzhenko T.V., Kobalava Z.D., Koziolova N.A., Koroteev A.V., Mareev Yu.V., Ovchinnikov A.G., Perepech N.B., Tarlovskaya E.I., Chesnikova A.I., Shevchenko A.O., Arutyunov G.P., Belenkov Yu.N., Galyavich A.S., Gilyarevsky S.R., Drapkina O.M., Duplyakov D.V., Lopatin Yu.M., Sitnikova M.Yu., Skibitsky V.V., Shlyakhto E.V. 2018. Klinicheskie rekomendatsii OSSN-RKO-RNMOT. Serdechnaya nedostatochnost: hronicheskaya (HSN) i ostraya dekompensirovannaya (ODSN). Diagnostika, profilaktika i lechenie. Kardiologiya [Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment]. Kardiologija, 58 (6S): 8–158.
Nikiforov V.S., Metso K.V. 2018. Elektrokardiograficheskie prediktoryi vnezapnoy serdechnoy smerti [Electrocardiographic predictors of sudden cardiac death]. Consilium Medicum, 20 (5): 29–33.
Pavlysh E.F., Hirmanov V.N., Pavlysh A.V. 2019. Serdechnaya nedostatochnost. Sovremennoe sostoyanie problemyi: dostizheniya, razocharovaniya, nadezhdyiiperspektivyi. Meditsinskiy sovet [Heart failure. The current state of the problem: achievements, frustrations, hopes and prospects] Medicinskij sovet, 6: 14–19.
Poljakov D.S., Fomin I.V., Vaysberg A.R. 2016. Epidemiologicheskaya programma EPOHA-HSN: dekompensatsiya hronicheskoy serdechnoy nedostatochnosti v realnoy klinicheskoy praktike (EPOHA-D-HSN). Serdechnaya Nedostatochnost [The EPOCH-CHF epidemiological program: decompensated chronic heart failure in real-life clinical practice (EPOCH-D-CHF)]. Serdechnaja Nedostatochnost', 17 (5): 299–305.
Poljakov D.S., Fomin I.V., Vajsberg A.R. 2019.EPOHA-D-HSN: gendernyie razlichiya v prognoze zhizni bolnyih HSN priostroy dekompensatsii serdechnoy nedostatochnosti (chast 2). Kardiologiya [EPOCHA-D-CHF: gender differences in the prognosis of patients with CHF af-ter acute decompensation (part 2)]. Kardiologija, 59 (4S): 33–43.
Rossijskoe kardiologicheskoe obshhestvo. Hronicheskaja serdechnaja nedostatochnost'. Klinicheskie rekomendacii [Russian Society of Cardiology (Chronic heart failure. Clinical guidelines 2020. Russian Journal of Cardiology]. 2020. Rossijskij kardiologicheskij zhurnal. 25 (11): 4083.
Fomin I.V. 2016. Hronicheskaya serdechnaya nedostatochnost v Rossiyskoy Federatsii: chto segodnya myi znaem i chto dolzhnyi delat. Rossiyskiy kardiologicheski yzhurnal [Chronic Heart Failure in the Russian Federation: What We Know Today and What We Should Do. Russian journal of cardiology], 8 (136): 7–13.
Apostolos Tsimploulis, Phillip H. Lam, Cherinne Arundel, Steven N. Singh, Charity J. Morgan, Charles Faselis, Prakash Deedwania, Javed Butler, Wilbert S. Aronow, Clyde W. Yancy, Gregg C. Fonarow, Ali Ahmed. 2018. Systolic Blood Pressure and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction. JAMA Cardiology. 3 (4): 288–297.
Benjamin E.J. 2019. Heart disease and stroke statistics-2019 update: a report From the American Heart Association. Circulation, 139 (10): e56-e528. doi: 10.1161/CIR.0000000000000659.
Christian Madelaire, Finn Gustafsson, Søren L. Kristensen, Maria D'Souza, Lynne W. Stevenson, Lars Kober, Christian Torp-Pedersen, Gunnar Gislason, Morten Schou. 2019. Burden and Causes of Hospital Admissions in Heart Failure During the Last Year of Life. JACC: Heart Failure, 7 (7): 561–570.
Clare J. Taylor, José M. Ordóñez-Mena, Andrea K. Roalfe, Sarah Lay-Flurrie, Nicholas R., Tom Marshall, F. D. Richard Hobbs. 2019. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000–2017: population based cohort study. British Medical Journal, 364: 1223.
Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E. Casey Jr., Monica M. Colvin, Mark H. Drazner, Gerasimos S. Filippatos, Gregg C. Fonarow, Michael M. Givertz, Steven M. Hollenberg, Jo Ann Lindenfeld, Frederick A. Masoudi, Patrick E. McBride, Pamela N. Peterson, Lynne Warner Stevenson, Cheryl Westlake. 2017. ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology, 70 (6): 776–803.
Domenico Scrutinio, Pietro Guida, Andrea Passantino, Rocco Lagioia, Rosa Raimondo, Mario Venezia, Enrico Ammirati, Fabrizio Oliva, Miriam Stucchi, Maria Frigerio. 2018. Female gender and mortality risk in decompensated heart failure. European Journal of Internal Medicine. 51: 34–40.
Evandro Tinoco Mesquita, Antonio José Lagoeiro Jorge, Luciana Morais Rabelo, Celso Vale Souza Jr. 2017. Understanding Hospitalization in Patients with Heart Failure. International Journal of Cardiovascular Sciences, 30 (1): 81–90.
Fragasso G. 2016. Deranged Cardiac Metabolism and the Pathogenesis of Heart Failure. Cardiac Failure Review, 2 (1): 8–13.
Inamdar A.A., Inamdar A.C. 2016. Heart Failure: Diagnosis, Management and Utilization.Journal of clinical medicine, 5 (7): 62.
Luiz E. Ritt, Antonio Carlos Carvalho, Gilson S. Feitosa, Joel A. Pinho-Filho, Cristiano R. B. Macedo, Fabio Vilas-Boas, Marcus V.S. Andrade, Gilson S. Feitosa-Filho, Augusto J.G. Almeida, Marcos Barojas, Renato D. Lopes, 2016. Heart Failure Survival Score in Patients With Chagas Disease, Correlation With Functional Variables. Revista Española de Cardiología, 65 (6): 538–543.
Malik A., Brito D., Chhabra L. Congestive Heart Failure. 2021. In: Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; Available from: https://www.ncbi.nlm.nih.gov/books/NBK430873/.
Monika Obiegło, Izabella Uchmanowicz, Marta Wleklik, Beata Jankowska-Polańska, Mateusz Kuśmierz. 2016. The effect of acceptance of illness on the quality of life in patients with chronic heart failure. European Journal of Cardiovascular Nursing, 15 (4): 241–247.
Nikolaidou T., Samuel N.A., Marincowitz C., Fox D.J., Cleland J.G.F., Clark A.L. 2020. Electrocardiographic characteristics inpatients with heart failuree and normal ejection fraction: A systematic review and metaanalysis. 5 (1): e12710, doi: 10.1111/anec.12710.
Nuria Farré, Emili Vela, Montse Clèries, Montse Bustins, Miguel Cainzos-Achirica, Cristina Enjuanes, Pedro Moliner, Sonia Ruiz, JoseMaria Verdú-Rotellar, Josep Comín-Colet. 2016. Medical resource use and expenditure in patients with chronic heart failure: a population based analysis of 88 195 patients. European Journal of Heart Failure, 18 (9): 1132–1140.
Ponikowski P.A., Voors A., D. Anker S., Bueno H., G.F. Cleland J., J.S. Coats A., Falk V., González-Juanatey J., Harjola V., A. Jankowska E., Jessup M., Linde C., Nihoyannopoulos P., T. Parissis J., Pieske B., P. Riley J., M.C. Rosano G., M. Ruilope L., Ruschitzka F., H. Rutten F., van der Meer P. 2016. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 37 (27): 2129–2200. doi: 10.1093/eurheartj/ehw128.
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, Larry A. Allen, Michael Chan, Akshay S. Desai, Anita Deswal, Victoria Vaughan Dickson, Mikhail N. Kosiborod, Carolyn L. Lekavich, Rozalina G. McCoy, Robert J. Mentz, Ileana L. Piña, American Heart Association Heart Failure and Transplantation Committee of the Councilon Clinical Cardiology; Councilon Cardiovascularand Stroke Nursing; and the Heart Failure Society of America. 2019. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation, 140 (7): 294–324.
Wen-Hong Ding, Ling Han, Yan-Yan Xiao, Ying Mo,Jing Yang, Xiao-Fang Wang, Mei Jin. 2017. Roleof. Whole-exome Sequencingin Phenotype Classification and Clinical Treatmentof Pediatric Restrictive Cardiomyopathy.130 (23): 2823–2828. doi: 10.4103/0366-6999.219150.